Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene's (CNC) second-quarter earnings suffer from rising operating expenses and a decline in Medicaid membership levels. Improved Marketplace membership growth partially offset the negatives.

Centene (CNC) Q2 Earnings Miss on Declining Medicaid Membership

Centene Corporation. (NYSE:CNC ) Q2 2024 Earnings Conference Call July 26, 2024 8:30 AM ET Company Participants Jennifer Gilligan - SVP, Finance and Investor Relations Sarah London - Chief Executive Officer Andrew Asher - EVP and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Josh Raskin - Nefron Research A.J.

Centene Corporation (CNC) Q2 2024 Earnings Call Transcript

The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Centene (CNC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

On Friday, Centene Corporation  CNC reported second-quarter sales of $39.84 billion, up 5.9% year-over-year, beating the consensus of $36.46 billion.

Health Insurer Centene's Q2 Premium Revenue Cushions Fall In Medicaid Enrollment, Raises Annual Outlook

Centene (CNC) came out with quarterly earnings of $2.42 per share, missing the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.10 per share a year ago.

Centene (CNC) Q2 Earnings Miss Estimates

Centene reported second quarter profits of $1.1 billion as Obamacare enrollment and premium revenue helped overcome a big dip in Medicaid enrollment.

Centene Profits Hit $1.1 Billion As Obamacare Offsets Drop In Medicaid

Centene Corp beat Wall Street estimates for second-quarter profit on Friday following the company's announcement that it was no longer required to make a $1.3 billion payment related to its government-sponsored Medicaid offerings.

Centene beats profit estimates after change in govt risk adjustment

-- Diluted E PS of $2.16; Adjusted Diluted EPS of $2.42 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80  -- Adjusted diluted EPS of $2.42 , up 15% from $2.10 in the second quarter  of 2023. Premium and service revenues of $36.0 billion in the second quarter of 2024.

CENTENE CORPORATION REPORTS SECOND QUARTER 2024 RESULTS

Cigna

UnitedHealth Group

Rising premiums, technological advancements and increased demand for Medicare plans are expected to drive the performances of the Zacks Medical-HMO industry players. UNH, CI and CNC are poised to benefit from encouraging industry prospects.

3 HMO Stocks Set to Thrive on a Varied Customer Base, Tech Investments

Astrana Health Inc

ALHAMBRA, Calif. , July 25, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana"), together with its subsidiaries and affiliated entities ("the Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced it has entered into a definitive agreement to acquire Collaborative Health Systems ("CHS"), a management services organization serving more than 129,000 beneficiaries across 17 states and a company of Centene Corporation (NYSE:CNC) ("Centene"), a leading healthcare enterprise focused on transforming the health of the communities it serves.

Astrana Health Enters Definitive Agreement to Acquire Collaborative Health Systems

Centene forecast second-quarter adjusted profit above Wall Street estimates, saying it does not have to make a previously expected payment under a "risk adjustment" program related to its government-backed Medicaid plans.

Health insurer Centene's upbeat quarterly profit forecast fails to impress

Beyond analysts' top -and-bottom-line estimates for Centene (CNC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.

Unlocking Q2 Potential of Centene (CNC): Exploring Wall Street Estimates for Key Metrics

Centene's (CNC) second-quarter results are likely to reflect growing contributions from its Commercial business.

Can Centene (CNC) Navigate Falling Memberships in Q2 Earnings?

Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Centene (CNC) to Report a Decline in Earnings: What to Look Out for

Bunge Global SA

Valero Energy

The Magnificent 7 have lost $1.11 trillion in market capitalization over the past five trading days as investors rotate away from them. Some of the capital moving away has likely gone into other, less overvalued S&P 500 stocks.

If You Can Only Buy One S&P 500 Stock in July, It Better Be One of These 3 Names

The New Facility is the Sixth Welcome Room to Open in North Carolina RALEIGH, N.C. , July 18, 2024 /PRNewswire/ -- WellCare of North Carolina  (WellCare), the Medicaid brand and wholly owned subsidiary of Centene Corporation (NYSE: CNC), announced today the grand opening of a new WellCare Welcome Room in Raleigh, a space to helps assist members about health plans and benefits, speak to WellCare representatives and access other healthcare resources.

WellCare Welcome Room Opens in Raleigh, Providing Healthcare Resources and Community Support

Archer-Daniels-Midland Company

AMC Entertainment

American Axle & Manufacturing Hlds

Dana Incorporated

Investors would do well to monitor stocks like American Axle (AXL), Dana (DAN), AMC Entertainment (AMC), Centene (CNC) and Archer Daniels (ADM) for higher returns.

5 Broker-Loved Stocks to Keep a Tab On as Inflation Cools

WASHINGTON--(BUSINESS WIRE)--Duo Health (“Duo”), a new type of value-based medical group purpose-built to manage chronic kidney disease (CKD) and end-stage kidney disease (ESKD), announced today it has entered into a strategic partnership with Arizona Complete Health, a company that provides and administers health benefits through individual, Medicaid, Medicare and dual-eligible programs and a Centene Corporation company (NYSE: CNC). This partnership builds on Arizona Complete Health's existing.

Duo Health Partners with Arizona Complete Health on Value-Based Care Program to Improve Outcomes for Members with Chronic Kidney Disease and End-Stage Kidney Disease

RALEIGH, N.C. , July 10, 2024 /PRNewswire/ -- Today WellCare of North Carolina (WellCare), a Medicaid health plan and subsidiary of Centene Corporation  (NYSE: CNC) has received Health Equity Accreditation Status by the National Committee for Quality Assurance (NCQA).

WellCare of North Carolina Receives NCQA Health Equity Accreditation Ahead of 2025 Requirement

Health Net Assisting Members During State of Emergency SACRAMENTO, Calif. , July 4, 2024 /PRNewswire/ -- In response to Gov.

Health Net Providing Special Assistance to Members Affected by Thompson Fire in Butte County

ST. LOUIS , July 2, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 second quarter financial results at approximately 6:00 a.m. ET on Friday, July 26, 2024, and host a conference call at 8:30 a.m.

CENTENE CORPORATION TO HOST 2024 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL

Partnership to Improve Behavioral Health Support for  Kansans with Intellectual and Developmental Disabilities LENEXA, Kan. , July 1, 2024 /PRNewswire/ -- Sunflower Health Plan ("Sunflower"), a managed care organization established to deliver quality healthcare in the state of Kansas and a wholly owned subsidiary of the Centene Corporation (NYSE: CNC), and Centene Foundation, the philanthropic arm of Centene Corporation, today announced a $200,000 grant to GoodLife Innovations ("GoodLife") to support behavioral health professionals who care for people with intellectual and developmental disabilities (IDD).

Sunflower Health Plan and Centene Foundation Announce $200,000 Grant to GoodLife Innovations

Health Net Assisting Members During State of Emergency SACRAMENTO, Calif. , June 25, 2024 /PRNewswire/ -- In response to Gov.

Health Net Providing Special Assistance to Members Affected by Winter Storms Throughout California

Centene (CNC) is expected to benefit from expanding margins in the Marketplace business, contract wins in Medicaid, and improved Medicare Advantage Star ratings.

Here's Why Investors Must Hold on to Centene (CNC) Stock Now

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

News for Centene Stock (CNC)